Dyonissios K.
- Country
- Italy
- Department
- Gynecology and obstetric
Research Overview
- Evaluation of Palonosetron and Netupitant as Antiemetic Therapy in Chemotherapy-Naïve Endometrial Cancer Patients Receiving Paclitaxel-Carboplatin Regimen.
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
- Randomized Evaluation of Paclitaxel-Carboplatin with Maintenance Niraparib versus Paclitaxel-Carboplatin-Bevacizumab with Maintenance Niraparib-Bevacizumab in Advanced Ovarian Cancer
Data & Insights
Has run more than one trial at 79 of 203 partner sites.
Specializations
Ovarian Cancer Research
Specializes in advanced treatment approaches for high-grade ovarian cancer, with particular focus on HRD-positive cases and low-grade serous epithelial ovarian carcinoma.
- Advanced FIGO stage cancers (IIIA-IV)
- Fallopian tube and peritoneal cancers
- Clear cell carcinoma management
Investigates hormone receptor-positive disease treatments and maintenance therapy strategies.
Cervical Cancer Treatment
Focuses on innovative therapeutic approaches for metastatic cervical carcinoma, incorporating targeted and immunotherapy combinations.
- Stage IVB cervical cancer
- Persistent cervical cancer
- Recurrent disease management
Explores combination therapies integrating immunotherapy with conventional treatment approaches.
Endometrial Cancer Studies
Specializes in treating MMR deficient endometrial cancer, with emphasis on advanced and metastatic disease scenarios.
- Advanced/metastatic endometrial cancer
- MMR deficient tumors
- First-line therapeutic strategies
Investigates novel immunotherapy approaches for specific molecular subtypes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.